Ichinoe Masaaki

イチノエマサアキ | Ichinoe Masaaki

Affiliation and department：

Research field (3)： Human pathology , Experimental pathology , Human pathology

Research theme for competitive and other funds (6)：

2021 - 2024 術前化学療法進行胃癌に対する治療効果とDNA修復関連蛋白REV7の発現との関連
2018 - 2021 Elucidation of novel molecular mechanisms for maintenance of spermatogonial stem cells and gametogenesis in the testis
2015 - 2018 Involvement of translesion DNA synthesis in the development of UV-induced skin cancer and its possible mechanisms
2011 - 2012 Elucidation of chemotherapy related factor of the preoperativechemotherapy for advanced gastric cancer and establishment of curative effect prediction system
2009 - 2010 Carcinogenic pathway and prognosis of gastric cancer in young patients : genome instability and DNA methylation

Show all

Papers (52)：

Akihiro Tamaki, Takuya Kato, Yasutaka Sakurai, Keita Sato, Kai Adachi, Masayoshi Tadehara, Taro Kogami, Masahiro Matsushita, Akiyoshi Hoshino, Itaru Sanoyama, et al. REV7 is involved in outcomes of platinum-based chemotherapy in pancreatic cancer by controlling the DNA damage response. Cancer science. 2024. 115. 2. 660-671
Kazu Shiomi, Masaaki Ichinoe, Ai Ushiwata, Koji Eshima, Ryo Nagashio, Shoko Hayashi, Dai Sonoda, Yasuto Kondo, Raito Maruyama, Masashi Mikubo, et al. Insight into the significance of CD8+ tumor-infiltrating lymphocytes in squamous cell lung cancer. Thoracic Cancer. 2023
Yuko Shimada, Takuya Kato, Yasutaka Sakurai, Hitoe Watanabe, Mayu Nonaka, Natsumi Nanaura, Masaaki Ichinoe, Yoshiki Murakumo. Identification of the promoter region regulating the transcription of the REV7 gene. Biochemical and biophysical research communications. 2023. 662. 8-17
Yoshiki Murakumo, Yasutaka Sakurai, Takuya Kato, Hiroshi Hashimoto, Masaaki Ichinoe. REV7 in Cancer Biology and Management. Cancers. 2023. 15. 6
SHOHEI TSUTSUMI, KAHO MOMIYAMA, MASAAKI ICHINOE, TAKUYA KATO, SACHIYO MOGI, SHUNSUKE MIYAMOTO, YOSHIKI MURAKUMO, TAKU YAMASHITA. The Significance of CD109 Expression in Oropharyngeal Squamous Cell Carcinoma. Anticancer Research. 2022. 42. 4. 2061-2070

ｍore...

MISC (131)：

ｍore...

Work history (2)：

Association Membership(s) (3)：

日本病理学会 , 日本臨床細胞学会 , 日本癌学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page